BONOMINI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 10.366
EU - Europa 7.320
AS - Asia 7.259
SA - Sud America 872
AF - Africa 115
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 18
Totale 25.968
Nazione #
US - Stati Uniti d'America 10.172
SG - Singapore 2.806
CN - Cina 2.063
IT - Italia 1.225
UA - Ucraina 1.144
IE - Irlanda 1.107
TR - Turchia 863
RU - Federazione Russa 840
SE - Svezia 742
GB - Regno Unito 678
BR - Brasile 677
VN - Vietnam 648
DE - Germania 539
FR - Francia 463
IN - India 357
FI - Finlandia 266
HK - Hong Kong 140
CA - Canada 111
PL - Polonia 69
AR - Argentina 62
JP - Giappone 54
MX - Messico 52
BD - Bangladesh 51
ZA - Sudafrica 48
NL - Olanda 47
AT - Austria 40
CZ - Repubblica Ceca 39
IQ - Iraq 38
KR - Corea 36
EC - Ecuador 34
ES - Italia 31
ID - Indonesia 29
CO - Colombia 27
BE - Belgio 26
CL - Cile 24
PY - Paraguay 18
IL - Israele 17
AU - Australia 16
EG - Egitto 16
SA - Arabia Saudita 16
UZ - Uzbekistan 16
IR - Iran 15
VE - Venezuela 15
EU - Europa 14
MA - Marocco 12
MY - Malesia 12
PK - Pakistan 12
JO - Giordania 11
NP - Nepal 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 8
LT - Lituania 8
AL - Albania 7
DZ - Algeria 7
LB - Libano 7
PH - Filippine 7
UY - Uruguay 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
PS - Palestinian Territory 6
SN - Senegal 6
TW - Taiwan 6
AZ - Azerbaigian 5
KE - Kenya 5
CG - Congo 4
EE - Estonia 4
ET - Etiopia 4
JM - Giamaica 4
NI - Nicaragua 4
NO - Norvegia 4
OM - Oman 4
TN - Tunisia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
PT - Portogallo 3
QA - Qatar 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
BB - Barbados 2
CY - Cipro 2
HR - Croazia 2
MK - Macedonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
SO - Somalia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 25.952
Città #
Singapore 1.912
Jacksonville 1.277
San Jose 1.204
Dublin 1.094
Chandler 1.052
Ashburn 777
Princeton 517
Beijing 453
Southend 450
Dallas 433
Izmir 418
Nanjing 356
Houston 352
Wilmington 276
Los Angeles 265
Ho Chi Minh City 231
Council Bluffs 219
Dearborn 219
Cambridge 209
Chieti 185
Santa Clara 181
Tongling 162
New York 155
Buffalo 147
Altamura 145
Nanchang 143
Ann Arbor 130
Hong Kong 129
The Dalles 126
Hanoi 118
Woodbridge 100
Munich 96
Moscow 91
Boardman 78
Shenyang 78
São Paulo 73
Hebei 68
Pescara 68
Washington 58
Hefei 57
Rome 56
Dong Ket 55
Redondo Beach 55
Jiaxing 54
Kunming 54
Tianjin 54
Warsaw 50
Tokyo 48
Orem 46
Milan 45
Brooklyn 38
Nuremberg 38
Helsinki 35
Jinan 35
Atlanta 33
London 33
Norwalk 32
Johannesburg 31
Montreal 31
Brno 30
Chennai 30
Da Nang 30
Hangzhou 30
Changsha 29
Seoul 29
Vittuone 29
Chicago 28
Denver 28
Ningbo 28
Haiphong 26
Seattle 26
Stockholm 26
Brussels 25
Frankfurt am Main 25
Toronto 25
Zhengzhou 24
Grevenbroich 23
Poplar 23
Amsterdam 21
Bari 21
Ottawa 21
Vienna 21
Augusta 20
Boston 20
Leawood 20
Turku 20
Shanghai 18
Düsseldorf 17
Kocaeli 17
Manchester 17
Phoenix 17
San Mateo 17
San Francisco 16
Guangzhou 15
Lappeenranta 15
Mexico City 15
Orange 15
Biên Hòa 14
Bologna 14
Lanzhou 14
Totale 15.824
Nome #
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia] 455
Therapy of glucocorticoid induced osteoporosis 270
Quali soluzioni future per la dialisi peritoneale? 222
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 196
Plasma protein carbonylation in chronic uremia 193
Epatotossicità acuta da amiodarone endovena in una paziente in emodialisi 189
Prognostic value of morphologic and morphometric analyses in IgA nephropathy biopsies 177
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 175
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 171
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 171
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 168
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 167
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 167
Calcimimetic R-568 vasodilatory effect effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs) 165
Emodiafiltrazione (HDF) con polisulfone (PSF) e neuropatia periferica: una valida alternativa al trattamento emodialitico tradizionale RDT) 162
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 160
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 159
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 158
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 157
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 156
A new polymethylmethacrylate membrane for hemodialysis 155
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 152
Proteomics characterization of protein adsorption onto hemodialysis membranes 151
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 151
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 150
Elettrofisiologia del sistema nervoso centrale e periferico in pazienti in trattamento sostitutivo: effetti della RDT e della CAPD 148
Alterazioni del trasporto di Na+ e Ca++ in sinaptosomi di encefalo di ratto uremico: vi è correlazione con la trasmissione sinaptica? 147
Valutazione dell'utilità del test al Captopril nella diagnostica dell'ipertensione renovascolare (IRV) 147
Effect of erythropoietin on primed leucocyte expression profile. 147
Severa neutropenia durante trattamento con amoxicillina/acido clavulanico in un paziente in trattamento emodialitico regolare [Severe neutropenia during treatment with amoxicillin/clavulanic acid in a patient on regular hemodialysis treatment] 145
Biocompatibility of DIAPES 144
L-Carnitine is an osmotic agent suitable for peritoneal dialysis 144
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 143
Examining hemodialyzer membrane performance using proteomic technologies 143
Proteomic Investigations into Hemodialysis Therapy 143
In vitro microbiology studies on a new peritoneal dialysis connector 140
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 140
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 139
Blood cell proteomics in chronic kidney disease 139
Urinary Peptidomic Biomarkers in Kidney Diseases 139
Thyroid function and plasma selenium in chronic uremic patients onhemodialysis treatment 138
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations 135
Current opinion on usage of L-carnitine in end-stage renal disease patients on peritoneal dialysis 135
Update sull'impiego della proteomica in emodialisi 134
Carnitine in metabolic disease: potential for pharmacological intervention 133
Defining the potential antidepressant mode of action of acetyl-l-carnitine. 133
Emodiafiltrazione (HDF) con membrane in polisulfone (PSF) ed eritropoietina ricombinante umana (r-HuEPO): si puo' fare di meglio? 132
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 131
Cellular properties of human erythrocytes preserved in saline-adenine-glucose-mannitol in the presence of L-carnitine 130
Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy 130
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests 129
Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter 129
Terapia sostitutiva artificiale della malattia renale cronica 129
Effects of L-carnitine administration on erythrocyte survival in haemodialysis patients 127
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 127
Thyroid function and selenium supplementation in dialytic patients affected by chronic renal failure 127
Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients 127
Extra-hepatic manifestations associated with Hepatitis and virus infection 127
Dislipidemia e progressione della insufficienza renale cronica 126
Carnitine palmitoyltransferase as a potential target for treating diabetes: is inhibition or activation preferable? 126
Metabolic Syndrome in Survivors from the 2009 Earthquake in Italy 126
Nefropatie tubulo-interstiziali iatrogene: patogenesi e quadro clinico 125
Alterazioni ematologiche nelle malattie renali e alterazioni renali in corso di malattie ematologiche 124
L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis 124
Emodiafiltrazione con polisulfone: effetti elettrofisiologici sulla neuropatia uremica 123
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate. 123
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 122
A rare case of acute tubular necrosis tenofovir alafenamide-related 122
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy 122
A new form of acute adverse reaction to icodextrin in a peritoneal dialysis patient 121
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure 121
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 120
Proteomic Characterization of a New asymmetric Cellulose Triacetate Membrane for Hemodialysis 120
Uremic toxicity and anemia 119
Removal of uremic plasma factors using different dialysis modalities 118
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 118
Use of oral hypoglycemic agents in patients with chronic kidney failure 118
L-carnitine in uremic anemia 116
Effetto ipolipemizzante della simvastatina nei pazienti in CAPD con ipercolesterolemia 115
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 115
Increased erythrocyte phosphatidylserine exposure in chronic renal failure 115
Alterazioni morfo-funzionali dell'apparato cardio-vascolare nei pazienti con malattia renale policistica autosomica dominante 115
Proteomic analysis of protein adsorption onto haemodialysis membranes 115
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. 115
Terapia ipolipemizzante nella insufficienza renale cronica 114
Hemodynamic-guided therapy in essential hypertension: a new pathophysiological approach 114
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 114
Glomerulopathies associated with psoriasis: a report of three cases 114
Effetto protettivo dei Ca++-antagonisti (CCB) sulla nefrotossicità da ciclosporina (CyA) 113
Miglioramento dell'attivita' elettrica cerebrale in pazienti uremici in trattamento emodialitico (RDT) dopo eritropoietina umana ricombinante (r-HuEPO) 113
Vascular inflammation in end-stage renal disease: the red blood cell connection 113
Selenium in uremia 111
ACHIEVEMENT OF NKF/K-DOQI RECOMMENDED TARGET VALUES FOR BONE AND MINERAL METABOLISM IN INCIDENT HEMODIALYSIS PATIENTS: RESULTS OF THE FARO-2 COHORT 111
Treatment of cutaneous calciphylaxis with sodium thiosulfate: two case reports and a review of the literature 110
Association of chronic microinflammation, progression of atherosclerosis and outcome in maintenance hemodialysis (HD): long term effect of dialytic membranes 110
New treatment approaches for the anemia of CKD 109
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 109
A moderate carnitine deficiency exacerbates isoproterenol-induced myocardial injury in rats 109
A Novel Formulation of Glucose-Sparing Peritoneal Dialysis Solutions with l-Carnitine Improves Biocompatibility on Human Mesothelial Cells 109
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 109
Totale 14.004
Categoria #
all - tutte 106.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021499 0 0 0 0 0 0 0 0 0 272 98 129
2021/20221.147 66 28 30 205 79 22 25 74 102 42 145 329
2022/20233.174 339 382 147 318 283 617 236 225 429 29 94 75
2023/20241.768 110 44 114 55 111 608 384 75 14 35 24 194
2024/20254.068 241 604 465 186 92 126 113 233 593 178 438 799
2025/20268.072 790 377 869 1.058 780 515 1.427 565 915 776 0 0
Totale 27.416